- Home
- HLN vs RLAY Comparison
HLN vs RLAY Comparison
Compare HLN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLN
- RLAY
- Stock Information
- Founded
- HLN 2022
- RLAY 2015
- Country
- HLN United Kingdom
- RLAY United States
- Employees
- HLN N/A
- RLAY N/A
- Industry
- HLN Package Goods/Cosmetics
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HLN Consumer Discretionary
- RLAY Health Care
- Exchange
- HLN Nasdaq
- RLAY Nasdaq
- Market Cap
- HLN 48.2B
- RLAY 576.1M
- IPO Year
- HLN N/A
- RLAY 2020
- Fundamental
- Price
- HLN $9.96
- RLAY $3.60
- Analyst Decision
- HLN Buy
- RLAY Strong Buy
- Analyst Count
- HLN 1
- RLAY 11
- Target Price
- HLN $10.95
- RLAY $18.40
- AVG Volume (30 Days)
- HLN 13.5M
- RLAY 1.5M
- Earning Date
- HLN 07-31-2025
- RLAY 08-05-2025
- Dividend Yield
- HLN 1.78%
- RLAY N/A
- EPS Growth
- HLN 38.94
- RLAY N/A
- EPS
- HLN 0.20
- RLAY N/A
- Revenue
- HLN $14,062,871,660.00
- RLAY $7,679,000.00
- Revenue This Year
- HLN $3.63
- RLAY $17.59
- Revenue Next Year
- HLN $4.37
- RLAY N/A
- P/E Ratio
- HLN $25.12
- RLAY N/A
- Revenue Growth
- HLN N/A
- RLAY N/A
- 52 Week Low
- HLN $8.68
- RLAY $1.78
- 52 Week High
- HLN $11.42
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- HLN 26.82
- RLAY 57.25
- Support Level
- HLN $10.01
- RLAY $3.50
- Resistance Level
- HLN $10.15
- RLAY $3.86
- Average True Range (ATR)
- HLN 0.11
- RLAY 0.18
- MACD
- HLN -0.04
- RLAY 0.02
- Stochastic Oscillator
- HLN 3.68
- RLAY 65.79
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).